➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
McKinsey
Mallinckrodt
Dow
Express Scripts

Last Updated: July 6, 2020

DrugPatentWatch Database Preview

Eugia Pharma Company Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for EUGIA PHARMA, and what generic and branded alternatives to EUGIA PHARMA drugs are available?

EUGIA PHARMA has ten approved drugs.

There is one tentative approval on EUGIA PHARMA drugs.

Summary for Eugia Pharma
US Patents:0
Tradenames:7
Ingredients:7
NDAs:10

Drugs and US Patents for Eugia Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Eugia Pharma LETROZOLE letrozole TABLET;ORAL 211717-001 Jan 11, 2019 AB RX No No   Start Trial   Start Trial
Eugia Pharma CARBOPLATIN carboplatin INJECTABLE;INTRAVENOUS 205487-001 Mar 28, 2016 DISCN No No   Start Trial   Start Trial
Eugia Pharma OXALIPLATIN oxaliplatin INJECTABLE;INTRAVENOUS 205529-001 Sep 6, 2017 AP RX No No   Start Trial   Start Trial
Eugia Pharma METHOTREXATE SODIUM methotrexate sodium TABLET;ORAL 210454-001 Jan 30, 2020 AB RX No No   Start Trial   Start Trial
Eugia Pharma HYDROXYPROGESTERONE CAPROATE hydroxyprogesterone caproate SOLUTION;INTRAMUSCULAR 211070-001 Apr 16, 2019 AP1 RX No No   Start Trial   Start Trial
Eugia Pharma HYDROXYPROGESTERONE CAPROATE hydroxyprogesterone caproate SOLUTION;INTRAMUSCULAR 211142-001 May 9, 2019 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Harvard Business School
Boehringer Ingelheim
Moodys
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.